Telmisartan Plus Tablet 80/12.5 mg

Adult dose

For patients whose blood pressure is not adequately controlled by telmisartan alone, this medication should be taken once daily with water, regardless of meals. Telmisartan/Hydrochlorothiazide combination 40/12.5 mg may be administered to patients whose blood pressure cannot be adequately controlled with 40 mg of telmisartan. Telmisartan/Hydrochlorothiazide combination 80/12.5 mg may be administered to patients whose blood pressure cannot be adequately controlled with 80 mg of telmisartan.

Child dose

The safety and efficacy of this medication have not been established in children under 18 years.

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by individuals with allergies to the active ingredients or excipients, those with certain liver or kidney diseases, pregnant or nursing women. Elderly patients or those with high potassium levels, liver impairment, or heart or blood vessel diseases should use this medication cautiously. The hydrochlorothiazide component can increase skin sensitivity to sunlight and raise the risk of skin cancer, so sun protection should be observed during use. While this medication lowers blood pressure, various side effects such as dizziness, hypotension, dyspepsia, and skin rashes may occur, so consult a doctor immediately if any abnormal symptoms arise. It is particularly important to regularly monitor potassium, sodium, and other electrolyte levels through blood tests, as imbalances may occur. This medication may interact with other antihypertensives, diuretics, lithium, certain antibiotics, and antidepressants, so all other medications being taken must be reported. If planning a pregnancy or pregnant, it is recommended to switch to other treatments with confirmed safety. Patients with significantly impaired liver or kidney function should not use this medication and should have liver and kidney functions periodically monitored during treatment. Overdose may lead to hypotension, electrolyte imbalances, and dehydration, so adherence to the prescribed dosage and administration is mandatory. The safety and efficacy of this medication have not been established in children and adolescents under 18 years. Dizziness, drowsiness, or fainting may occur during treatment, so caution is advised while driving or operating machinery. This medication is sensitive to moisture, so it should be taken out of its sealed packaging just before use and stored out of reach of children.

Serious side effects

• Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions
• Severe rash accompanied by fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin abnormal reactions
• Shortness of breath or difficulty in breathing, asthma attacks, respiratory issues accompanied by cough and fever
• Skin or eyes turning yellow (jaundice), severe fatigue, liver abnormalities (jaundice)
• Sudden and very severe headache

Mild side effects

Bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, visual disturbances, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, respiratory discomfort, pneumonia, diarrhea, dry mouth, bloating, abdominal pain, constipation, dyspepsia, vomiting, liver function abnormalities/liver impairment, erythema, pruritus, rash, sweating, urticaria, lower back pain, muscle cramps

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1°C and 30°C to ensure the safety of the medication's efficacy.

Appearance

White or nearly white, round, biconvex tablets

Package unit

30 tablets (10 tablets/PTP*3)/case, 100 tablets/bottle